Patent · US Active

Methods of using factor B inhibitors

US11951101B2 · kind B2 · utility

1Cited by

0References

38Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Irina BALTCHEVA · Oberwil, CH
Peter End · Oberwil, CH
Julie Marie-Pomme Gabrielle MILOJEVIC · Village-Neuf, FR

Key dates

Filing date	Jul 15, 2021
Grant date	Apr 9, 2024
Priority date	—
Expiry date	Jul 15, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are methods of treating paroxysmal nocturnal hemoglobinuria (PNH) with the Factor B inhibitor LNP023 or a pharmaceutically acceptable salt thereof, e.g. LNP023 hydrochloride.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.